VMP 27623511000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Dolutegravir 50mg / Abacavir 600mg / Lamivudine 300mg tablets
BNF code 050301000BBADA0
Virtual Therapeutic Moiety Dolutegravir + Abacavir + Lamivudine
Abbreviated name Dolutegravir 50mg / Abacavir 600mg / Lamivudine 300mg tab
Basis of preferred name Other
Date of name applicability 2 Apr 2025
Previous name Generic Triumeq 50mg/600mg/300mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Abacavir sulfate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 387005008
Strength value numerator 600.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Lamivudine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 300.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Dolutegravir sodium
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 713464000
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
Virtual Medicinal Product Packs
Dolutegravir 50mg / Abacavir 600mg / Lamivudine 300mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.

Feedback